Total planned funding: $886,229,771
Allocations
Countries/Regions
South Africa | $499,548,337 |
Nigeria | $75,592,314 |
Ethiopia | $57,267,237 |
Uganda | $53,162,384 |
Zambia | $51,722,575 |
Zimbabwe | $39,365,618 |
Haiti | $33,700,156 |
Lesotho | $13,544,685 |
Malawi | $10,901,910 |
Kenya | $10,714,497 |
Botswana | $7,491,833 |
Côte d'Ivoire | $6,645,597 |
Mozambique | $4,768,943 |
Tanzania | $4,032,036 |
Rwanda | $3,667,435 |
Ukraine | $3,600,000 |
Dominican Republic | $3,084,799 |
Guyana | $1,883,000 |
Cameroon | $1,427,352 |
Vietnam | $1,037,941 |
Caribbean Region | $773,605 |
Ghana | $749,399 |
Namibia | $613,118 |
Indonesia | $600,000 |
India | $205,000 |
Eswatini | $120,000 |
Democratic Republic of the Congo | $10,000 |
Organizational Types
Implementing Agency | $886,229,771 |
Program Areas
Treatment | $886,229,771 |
Budget Codes
HTXS: Treatment: Adult Treatment | $751,618,341 |
HTXD: Treatment: ARV Drugs | $67,563,098 |
PDTX: Treatment: Pediatric Treatment | $67,048,332 |
Top Partner Programs
University of the Witwatersrand:
$228,194,946
View countries
Anova Health Institute:
$146,625,927
View countries
TB/HIV Care Association:
$55,419,252
View countries
John Snow, Inc:
$50,161,531
View countries